POLYMYXIN for Anti-infective therapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where POLYMYXIN was used for Anti-infective therapy.
Most Reported Side Effects for POLYMYXIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 19 | 20.2% | 0 | 1 |
| Drug ineffective | 15 | 16.0% | 7 | 3 |
| Off label use | 12 | 12.8% | 3 | 6 |
| Myasthenia gravis crisis | 8 | 8.5% | 0 | 6 |
| Condition aggravated | 7 | 7.5% | 0 | 1 |
| Acute kidney injury | 6 | 6.4% | 2 | 0 |
| Erythema | 6 | 6.4% | 0 | 4 |
| Pyrexia | 5 | 5.3% | 1 | 4 |
Other Indications for POLYMYXIN
Product used for unknown indication (19)
Acinetobacter infection (5)
Covid-19 pneumonia (5)
Pneumonia (5)
Other Drugs Used for Anti-infective therapy
CILASTATIN\IMIPENEM (556)
LINEZOLID (305)
PIPERACILLIN\TAZOBACTAM (300)
MEROPENEM (241)
TIGECYCLINE (216)
MOXIFLOXACIN (197)
VANCOMYCIN (138)
AZITHROMYCIN (133)
VORICONAZOLE (114)
CEFOPERAZONE\SULBACTAM (106)